Abstract
While research provides new opportunities for diagnosing and treating patients with allergic and immunological disorders, there are significant challenges to putting these advances into use in clinical practice. Each new test may require clinicians in private practice to battle with a health insurer's designated clinical laboratory in an effort to get this new test and other accurate immunological laboratory studies. A new test may or may not be covered by some health care plans and may or may not be available from their designated laboratories. Many of these laboratories send time-sensitive samples across the country with risk of time delays and poor specimen handling leading to inaccurate results and/or the need to send repeat specimens. The growing role of managed care in every medical decision has led to frustrations for the patient and physician. This frequently requires a consult at a tertiary care center, where laboratory studies may be more easily accessible with fewer restrictions.
Where are the new opportunities? Some are found in the enhanced ability to make intelligent decisions in the diagnosis and treatment of immunological diseases. There is now a greater selection and availability of intravenous γ-globulin (IVIG), that can be matched to individual patient needs. The appropriate selection of these products will decrease adverse reactions and increase safety. There was a major advance in the treatment of moderate and severe asthma with the addition of omalizumab therapy. It provides allergists and immunologists with their first monoclonal humanized anti-IgE antibody.
Similar content being viewed by others
References
Ballow, M., and O'Neil, K. M. (1998), in Allergy Principles and Practice, vol. 2, 5th ed. Middleton, E., Jr., Reed, C. E., Ellis, E. F., Adkinson, N. F., Jr., Younger, J. W., and Busse, W. W., eds., Mosby, St. Louis, MO, pp. 735–759.
Buckley, R. H. (1988), in Allergy Principles and Practice, vol. 2, Middleton, E., Jr., Reed, C. E., Ellis, E. F., Adkinson, N. F., Jr., Younginger, J. W., and Bussee, W. W., eds., Mosby, St. Louis, MO, pp. 713–734.
Conley, M. E., Notarangelo, L. D., and Etzioni, A. (1999), Clin. Immunol. 93, 190–197.
Polmar, S. H., and Sorensen, R. U. (1996), in Clinical Immunology Principles and Practice, vol. 2, Rich, R. R., Fleisher, T. A., Schwartz, B. D., Shearer, W. T., and Strober, W., eds., Mosby, St. Louis, MO, pp. 1865–1875.
Al-Herz, W., and McGeady, S. J. (2003), Ann. Allergy Asthma Immunol. 90, 244–247.
AAAAI survey on immune deficiency practices. (2003), American Academy of Allergy, Asthma, and Immunology.
Bonilla, F. A., and Geha, R. S. (2003), J. Allergy Clin. Immunol. 111, S571-S581.
Burks, A. W., Sampson, H. A., and Buckley, R. H. (1986), N. Engl. J. Med. 314, 560–564.
Schur, P. H. (1987), Ann. Allergy 58, 89–99.
Schur, P. H., Borel, H., Gelfand, E. W., Alper, C.A., and Rosen, F. S. (1970), N. Engl. J. Med. 283, 631–634.
Silk, H. J., Ambrosino, D., and Geha, R. S. (1990), Ann. Allergy 64, 21–25.
Knutsen, A. P. (1989), J. Allergy Clin. Immunol. 84, 640–647.
Duncan, J. M., Herrod, H. G., and Crawford, L. V. (1988), Pediatric Asthma Allergy Immunol. 2, 269–278.
Rothbach, C., Nagel, J., Rabin, B., and Fireman, P. (1979), J. Pediat. 94, 250–253.
Ambrosino, J. B., and Finberg, R. W. (1987), N. Engl. J. Med. 316, 790–793.
Ambrosino, D. M., Umetsu, D. T., Siber, G. R., et al. (1988), J. Allergy Clin. Immunol. 81, 1175–1179.
Cunningham-Rundles, C., Siegal, F. P., Smithwick, E. M., et al. (1984), Ann. Intern. Med. 101, 435–439.
Watts, W. J., Watts, M. B., Dai, W., Cassidy, J. T., Grum, C. M., and Weg, J. G. (1986), Am. Rev. Respir. Dis. 134, 699–703.
Sweinberg, S. K., Wodell, R. A., Grodofsky, M. P., Greene, J. M., and Conley, M. E. (1991), J. Allergy Clin. Immunol. 88, 96–104.
Busse, P. J., Razvi, S., and Cunningham-Rundles, C. (2002), J. Allergy Clin. Immunol. 109, 1001–1004.
Roifman, C. M., Schroeder, H., Berger, M., et al. (2003), Inter. Immunopharmacol. 3, 1325–1333.
Roifman, C. M., Levison, H., and Gelfand, E. W. (1987), Lancet 1(8541), 1075–1077.
Gelfand, E. W., Reid, B., and Roifman, C. M. (1988), Monogr. Allergy 23, 177–186.
Eijkhout, H. W., van Der Meer, J. W., Kallenberg, C. G., et al. (2001), Ann. Intern. Med. 135, 165–174.
Gelfand, E. W. (1993), Clin. Infect. Dis. 17, 250–253.
Sorensen, R. U., Tomford, J. W., Gyves, M. T., Judge, N. E., and Polmar, S. H. (1984), Am. J. Med. 76, 73–77.
Berger, M., Cupps, T. R., and Fauci, A. S. (1982), JAMA 247, 2824–2825.
Trejo, S. R., Hotta, J. A., Lebing, W., et al. (2003), Vox Sang. 84, 176–187.
Omar, A., and Kempf, C. (2002), Transfusion 42, 1005–1010.
Gregori, L., Maring, J. A., MacAuley, C., et al. (in press), Biologicals.
Siegel, J. (2003), Pharm. Practice News January, 17–19.
Schleis, T. (2000), J. Intravenous Nursing 55, S23-S31.
CDC. (1994), MMWR 43, 505–509.
Stiehm, E. R., Casillas, A. M., Finkelstein, J. Z., et al. (1998), J. Allergy Clin. Immunol. 101, 848–849.
Day, P. B., Evans, J. H., Kobayashi, R. H., et al. (1991), Ann. Allergy 67, 504–510.
Nydegger, U. E., and Sturzenegger, M. (1999), Drug Safety 21, 171–185.
Brown, H. C., and Ballas, Zk. (2003), J. Allergy Clin. Immunol. 112, 797–799.
Pierce, L. R., and Jain, N. (2003), Trans. Med. Rev. 17, 241–251.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stein, M.R. Clinical immunology in practice, new opportunities. Clinic Rev Allerg Immunol 27, 83–91 (2004). https://doi.org/10.1385/CRIAI:27:2:083
Issue Date:
DOI: https://doi.org/10.1385/CRIAI:27:2:083